18 results on '"Bury, Roxana"'
Search Results
2. Biopsia renal transyugular. La alternativa a la biopsia percutánea en pacientes de alto riesgo
3. #5710 CHARACTERIZATION OF RESPONSE TO TREATMENT WITH RITUXIMAB IN PATIENTS WITH PRIMARY GLOMERULOPATIES
4. The Presence of ANCA in IgA Crescentic Nephropathy Does Not Lead to Worse Prognosis with Intensive Rescue Treatment
5. COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?
6. MO151CLINICAL COURSE AND OUTCOMES OF COVID-19 PATIENTS WITH BIOPSY-PROVEN GLOMERULAR AND TUBULAR KIDNEY DISEASE. LOW HEMOGLOBIN LEVELS AS A RISK FACTOR FOR MORTALITY
7. MO160COVID-19 INFECTION AND ACUTE TUBULOINTERSTITIAL NEPHRITIS
8. MO141ACUTE KIDNEY INJURY AS A RISK FACTOR FOR MORTALITY IN ONCOLOGICAL PATIENTS RECEIVING CHECK-POINT INHIBITORS
9. MO308COULD THE PRESENCE OF ANCAS IN IGA NEPHROPATHY WITH CRESCENTS HAVE A CLINICAL IMPLICATION?
10. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors.
11. Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors
12. COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease
13. Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?
14. P0453BIOSIMILAR RITUXIMAB AND BRAND RITUXIMAB: RELAPSES AND PROTEINURIA IN THE GLOMERULAR PRYMARY DISEASES
15. TO017CLINICAL CHARACTERISTICS AND INDEPENDENT PREDICTORS OF CHECK POINT INHIBITORS-ASSOCIATED AKI: WHAT DO WE KNOW?
16. Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
17. Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.
18. FP104UTILITY OF TRANSYUGULAR RENAL BIOPSY AS AN ALTERNATIVE TO PERCUTANEOUS BIOPSY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.